SRx Health Solutions Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Toronto, Ontario–(Newsfile Corp. – April 9, 2024) – SRx Health Solutions Inc., a leading Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre.

Dates: Tuesday April 16, 2024-Wednesday April 17, 2024
Time: 8:30 AM-5:00 PM ET
Location:  Metro Toronto Convention Centre,
North Building 255 Front St W
Toronto, Ontario
M5V 2W6


Adesh Vora, President and CEO, and Dr. Hemant Shah, Chief Medical Officer, will be speaking at 10:30AM ET on April 17th. Interested parties can register to attend here.

Members of the SRx Health Solutions Inc. management team will also be taking meetings throughout the day.

To register for the 2024 Bloom Burton & Co. Healthcare Investor Conference, please follow this link.

About SRx Health Solutions Inc.

SRx operates as a Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. Distinguishing itself as a National Specialty Pharmacy provider, SRx concentrates on overseeing a patient’s healthcare journey, spanning from acute pharmaceutical needs to chronic and rare disease management. This unique focus positions SRx to deliver a more holistic and integrated solution, catering to the requirements of both patients and key healthcare stakeholders. Our all-encompassing end-to-end offerings include wholesale/distribution facilities, patient support programs, infusion clinics, retail pharmacies, co-designed clinical programs, clinical trials, and diagnostic services. Our strategic growth plan is forward-thinking and revolves around fostering increased collaboration with pharmaceutical manufacturers and prescribers. With a specific emphasis on the expanding market of chronic and rare diseases, we target specialty drugs associated with closed and limited distribution networks. The objective is to broaden their distribution and improve accessibility. Our overarching goal is to elevate our current presence from 34 to 100 specialty pharmacy locations across mid-sized population centers throughout Canada, thereby enhancing the scope of healthcare services and establishing new industry benchmarks. In the subsequent phase of SRx’s evolution, we aim to extend our reach beyond the borders of Canada. Leveraging our comprehensive  approach, we aspire to simplify healthcare on a global scale. For more information on SRx, please visit:

About the Conference: 

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.

About Bloom Burton & Co.:

Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, industry and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, strategic advisory, as well as company creation and incubation services. Bloom Burton Securities Inc. is a member of the Canadian Investment Regulatory Organization (CIRO) and is also a member of the Canadian Investor Protection Fund (CIPF).

For questions and further information please contact:
Dave Sohi

error: Content is protected !!